Commonly used soft-tissue protocols include 250 mcg once daily, 500 mcg once daily, or 250 mcg twice daily
Solutions: Use a higher concentration with smaller reconstitution volume, which does not actually solve the stability issue since the same amount of time passes Start at a higher dose point if your protocol allows (only if you have already titrated up with a smaller vial) Consider aliquoting into smaller sterile vials and freezing portions for later use (reduces contamination risk to the main vial) Share the reconstitution timing with your dosing schedule, only reconstituting when you are at a dose where you will use the vial within 28-60 days For researchers at 10 mg or 15 mg weekly, the 60 mg vial is perfect
Cardiovascular disease: Monitor blood pressure due to potential NO interaction Autoimmune disorders: Consider immune modulation risks with chronic peptide use Cancer history: Use with caution due to angiogenesis stimulation Always consult a healthcare provider if you have any preexisting medical condition or take prescription medications
[1] Understanding Epithalon requires moving through three distinct but interconnected research domains: telomere biology and telomerase regulation, pineal gland neuroendocrinology, and chromatin remodeling in the context of cellular aging
In the central nervous system, glycine functions as a neurotransmitter with dual properties
Veterinary Restriction: Federal law limits this product to use only by or under the order of a licensed veterinarian